Stephanie J. Muriglan

2.2k citations

22 papers · 1.6k indexed · h-index 16

Co-authors: Marcel R.M. van den Brink Önder Alpdoğan Jeffrey M. Eng Barry J. Kappel Lucy Willis Andrew S. Greenberg Cornelius Schmaltz Vanessa M. Hubbard
Topics: Hematopoietic Stem Cell Transplantation (16 papers)T-cell and B-cell Immunology (14 papers)Immune Cell Function and Interaction (13 papers)
Cited by: Hematology Immunology Oncology
Journals: Journal of Clinical Investigation Nature Medicine The Journal of Experimental Medicine
Partner nations: United States Australia Japan

In The Last Decade

Stephanie J. Muriglan

22 papers receiving 1.6k citations

Peers

Countries citing papers authored by Stephanie J. Muriglan

Since Specialization

Citations

This map shows the geographic impact of Stephanie J. Muriglan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephanie J. Muriglan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephanie J. Muriglan more than expected).

Fields of papers citing papers by Stephanie J. Muriglan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephanie J. Muriglan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephanie J. Muriglan. The network helps show where Stephanie J. Muriglan may publish in the future.

Co-authorship network of co-authors of Stephanie J. Muriglan

This figure shows the co-authorship network connecting the top 25 collaborators of Stephanie J. Muriglan. A scholar is included among the top collaborators of Stephanie J. Muriglan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephanie J. Muriglan. Stephanie J. Muriglan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Enhanced Immune Reconstitution by Sex Steroid Ablation following Allogeneic Hemopoietic Stem Cell Transplantation 2007 ·The Journal of Immunology ·Gabrielle L. Goldberg,Önder Alpdoğan,Stephanie J. Muriglan,Maree V. Hammett,(unknown),Jeffrey M. Eng,Vanessa M. Hubbard,Adam A. Kochman,Lucy Willis,Andrew S. Greenberg,(unknown),Jayne S. Sutherland,Ann P. Chidgey,Marcel R.M. van den Brink,Richard L. Boyd	65
2	Adoptive transfer of in vitro generated T cell precursors improves T cell reconstitution and mediates graft-versus-tumor activity without graft-versus-host disease in allogeneic hematopoietic stem cell transplantation recipients 2006 ·Biology of Blood and Marrow Transplantation ·(unknown),Adam A. Kochman,Sydney X. Lu,Theis H. Terwey,(unknown),Vanessa M. Hubbard,Stephanie J. Muriglan,David Suh,Javier Cabrera-Pérez,Glenn Heller,(unknown),Önder Alpdoğan,Marcel R.M. van den Brink	1
3	CC chemokine receptor 2 is involved in intestinal homing of alloreactive donor CD8+ T cells during GVHD 2005 ·Biology of Blood and Marrow Transplantation ·Theis H. Terwey,Adam A. Kochman,Jeffrey M. Eng,Vanessa M. Hubbard,Stephanie J. Muriglan,Elisha Waldman,Johannes L. Zakrzewski,Önder Alpdoğan,Marcel R.M. van den Brink	1
4	Absence of β7 integrin results in less graft-versus-host disease because of decreased homing of alloreactive T cells to intestine 2005 ·Blood ·Elisha Waldman,Sydney X. Lu,Vanessa M. Hubbard,Adam A. Kochman,Jeffrey M. Eng,Theis H. Terwey,Stephanie J. Muriglan,Theo D. Kim,Glenn Heller,George F. Murphy,Chen Liu,Önder Alpdoğan,Marcel R.M. van den Brink	84
5	Adoptive transfer of in vitro-generated T cell precursors enhances posttransplant donor T cell reconstitution in recipients of an allogeneic hematopoietic stem cell transplantation 2005 ·Biology of Blood and Marrow Transplantation ·(unknown),Adam A. Kochman,Stephanie J. Muriglan,Sydney X. Lu,(unknown),(unknown),Önder Alpdoğan,Marcel R.M. van den Brink	1
6	Absence of inducible costimulator on alloreactive T cells reduces graft versus host disease and induces Th2 deviation 2005 ·Blood ·Vanessa M. Hubbard,Jeffrey M. Eng,Teresa Ramirez‐Montagut,(unknown),Stephanie J. Muriglan,Adam A. Kochman,Theis H. Terwey,Lucy Willis,(unknown),(unknown),George F. Murphy,Chen Liu,Önder Alpdoğan,Marcel R.M. van den Brink	34
7	Adoptive Transfer of In Vitro Generated T Cell Precursors Enhances Donor T Cell Reconstitution and Graft-Versus-Tumor Activity in Allogeneic Hematopoietic Stem Cell Transplantation Recipients. 2005 ·Blood ·Johannes L. Zakrzewski,Adam A. Kochman,Sydney X. Lu,Theis H. Terwey,Theo D. Kim,Vanessa M. Hubbard,Stephanie J. Muriglan,David Suh,Javier Cabrera-Pérez,Radhika Radhakrishnan,Glenn Heller,Juan Carlos Zúñiga‐Pflücker,Önder Alpdoğan,Marcel R.M. van den Brink	1
8	Keratinocyte growth factor (KGF) is required for post-natal thymic regeneration 2005 ·Biology of Blood and Marrow Transplantation ·Önder Alpdoğan,Vanessa M. Hubbard,Stephanie J. Muriglan,Gabrielle L. Goldberg,Adam A. Kochman,Jeffrey M. Eng,Odette M. Smith,Richard L. Boyd,Marcel R.M. van den Brink	15
9	Keratinocyte growth factor (KGF) is required for postnatal thymic regeneration 2005 ·Blood ·Önder Alpdoğan,Vanessa M. Hubbard,Odette M. Smith,Neel Patel,Sydney X. Lu,Gabrielle L. Goldberg,Daniel H.D. Gray,Jared W. Feinman,Adam A. Kochman,Jeffrey M. Eng,David Suh,Stephanie J. Muriglan,Richard L. Boyd,Marcel R.M. van den Brink	169
10	CCR2 is required for CD8-induced graft-versus-host disease 2005 ·Blood ·Theis H. Terwey,Theo D. Kim,Adam A. Kochman,Vanessa M. Hubbard,Sydney X. Lu,Johannes L. Zakrzewski,Teresa Ramirez‐Montagut,Jeffrey M. Eng,Stephanie J. Muriglan,Glenn Heller,George F. Murphy,Chen Liu,Tülin Budak-Alpdoǧan,Önder Alpdoğan,Marcel R.M. van den Brink	88
11	Keratinocyte Growth Factor (KGF) Is Required for Post-Natal Thymic Regeneration. 2004 ·Blood ·Önder Alpdoğan,Vanessa M. Hubbard,Stephanie J. Muriglan,Adam A. Kochman,Jeffrey M. Eng,Johannes L. Zakrzewski,Gabrielle L. Goldberg,Odette M. Smith,Elisha Waldman,Marcel R.M. van den Brink	1
12	GITR Activation Induces an Opposite Effect on Alloreactive CD4+ and CD8+ T Cells in Graft-Versus-Host Disease 2004 ·The Journal of Experimental Medicine ·Stephanie J. Muriglan,Teresa Ramirez‐Montagut,Önder Alpdoğan,(unknown),Jeffrey M. Eng,Vanessa M. Hubbard,Adam A. Kochman,(unknown),Carlo Riccardi,Pier Paolo Pandolfi,Shimon Sakaguchi,Alan N. Houghton,Marcel R.M. van den Brink	81
13	Interleukin-15 enhances immune reconstitution after allogeneic bone marrow transplantation 2004 ·Blood ·Önder Alpdoğan,Jeffrey M. Eng,Stephanie J. Muriglan,Lucy Willis,Vanessa M. Hubbard,(unknown),Theis H. Terwey,Adam A. Kochman,Marcel R.M. van den Brink	109
14	IL-7 enhances peripheral T cell reconstitution after allogeneic hematopoietic stem cell transplantation 2003 ·Journal of Clinical Investigation ·Önder Alpdoğan,Stephanie J. Muriglan,Jeffrey M. Eng,Lucy Willis,Andrew S. Greenberg,Barry J. Kappel,Marcel R.M. van den Brink	132
15	IL-7 enhances peripheral T cell reconstitution after allogeneic hematopoietic stem cell transplantation 2003 ·Journal of Clinical Investigation ·Önder Alpdoğan,Stephanie J. Muriglan,Jeffrey M. Eng,Lucy Willis,Andrew S. Greenberg,Barry J. Kappel,Marcel R.M. van den Brink	124
16	T cells require TRAIL for optimal graft-versus-tumor activity 2002 ·Nature Medicine ·Cornelius Schmaltz,Önder Alpdoğan,Barry J. Kappel,Stephanie J. Muriglan,Jimmy A. Rotolo,(unknown),Lucy Willis,Andrew S. Greenberg,Jeffrey M. Eng,James M. Crawford,George F. Murphy,Hideo Yagita∥,Henning Walczak,Jacques J. Peschon,Marcel R.M. van den Brink	121
17	T cells require TRAIL for optimal graft-versus-tumor activity 2002 ·Nature Medicine ·Cornelius Schmaltz,Önder Alpdoğan,Barry J. Kappel,Stephanie J. Muriglan,Jimmy A. Rotolo,(unknown),Lucy Willis,Andrew S. Greenberg,Jeffrey M. Eng,James M. Crawford,George F. Murphy,Hideo Yagita∥,Henning Walczak,Jacques J. Peschon,Marcel R.M. van den Brink	15
18	Differential use of Fas ligand and perforin cytotoxic pathways by donor T cells in graft-versus-host disease and graft-versus-leukemia effect 2001 ·Blood ·Cornelius Schmaltz,Önder Alpdoğan,(unknown),Stephanie J. Muriglan,Barry J. Kappel,Takanori Teshima,James L.M. Ferrara,Steven J. Burakoff,Marcel R.M. van den Brink	154
19	Hyper Immunoglobulin E Response in Mice with Monoclonal Populations of B and T Lymphocytes✪ 2001 ·The Journal of Experimental Medicine ·Maria A. Curotto de Lafaille,Stephanie J. Muriglan,Mary Jean Sunshine,Ying Lei,Nino Kutchukhidze,Gláucia C. Furtado,Allen Wensky,Danyvid Olivares–Villagómez,Juan J. Lafaille	87
20	Administration of interleukin-7 after allogeneic bone marrow transplantation improves immune reconstitution without aggravating graft-versus-host disease 2001 ·Blood ·Önder Alpdoğan,Cornelius Schmaltz,Stephanie J. Muriglan,Barry J. Kappel,Miguel‐Angel Perales,Jimmy A. Rotolo,Jens A. Halm,Benjamin E. Rich,Marcel R.M. van den Brink	162

About Stephanie J. Muriglan

Stephanie J. Muriglan is a scholar working on Hematology, Immunology and Transplantation, having authored 22 papers that have together received 1.6k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (16 papers), T-cell and B-cell Immunology (14 papers) and Immune Cell Function and Interaction (13 papers). The work is most often cited by research in Hematology (837 citations), Immunology (1.2k citations) and Oncology (375 citations). Stephanie J. Muriglan has collaborated with scholars based in United States, Australia and Japan. Frequent co-authors include Marcel R.M. van den Brink, Önder Alpdoğan, Jeffrey M. Eng, Barry J. Kappel, Lucy Willis, Andrew S. Greenberg, Cornelius Schmaltz, Vanessa M. Hubbard, Adam A. Kochman and Jimmy A. Rotolo. Their work appears in journals such as Journal of Clinical Investigation, Nature Medicine and The Journal of Experimental Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact